Infectious Diseases and Therapy (May 2020)

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group

  • Dimitrios Velissaris,
  • George Dimopoulos,
  • John Parissis,
  • Zoi Alexiou,
  • Nikolaos Antonakos,
  • Dimitrios Babalis,
  • Styliani Gerakari,
  • Vassileios Kaldis,
  • Pantelis Koutoukas,
  • Malvina Lada,
  • Konstantinos Leventogiannis,
  • Ioannis Pantazopoulos,
  • Antonios Papadopoulos,
  • Eftihia Polyzogopoulou,
  • Charalambos Gogos,
  • Apostolos Armaganidis,
  • Evangelos J. Giamarellos-Bourboulis

DOI
https://doi.org/10.1007/s40121-020-00301-w
Journal volume & issue
Vol. 9, no. 3
pp. 407 – 416

Abstract

Read online

Abstract In light of the accumulating evidence on the negative predictive value of soluble urokinase plasminogen activator receptor (suPAR), a group of experts from the fields of intensive care medicine, emergency medicine, internal medicine and infectious diseases frame a position statement on the role of suPAR in the screening of patients admitted to the emergency department. The statement is framed taking into consideration existing publications and our own research experience. The main content of this statement is that sUPAR is a non-specific marker associated with a high negative predictive value for unfavourable outcomes; levels 6 ng/ml are an alarming sign of risk for unfavourable outcomes. However, the suPAR levels should always be interpreted in light of the patient's history.

Keywords